Dr. Daniel Aviv Brill, MD

Dr. Brill practices at MVS Podiatry Associates - Rosedale in Baltimore, Maryland.

Dr. Brill's NPI, 1457700445, was assigned on June 9, 2016. Dr. Brill holds Maryland license D0097495.

Dr. Brill's primary practice is MVS Podiatry Associates - Rosedale, at 9114 Philadelphia Road, Suite 308, Baltimore, MD 21237. The practice phone is (410) 574-3900.

Dr. Brill's primary practice is MVS Podiatry Associates - Rosedale in Baltimore, Maryland. Dr. Brill is also affiliated with Greater Baltimore Medical Center. Dmand AI also links Dr. Brill to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brill practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Brill's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Brill is licensed in Maryland.

CMS data shows 6,040 Medicare services from Dr. Brill across 17 procedure codes in 2024, for 590 Medicare patients. Medicare paid $437,011 for them.

CMS counts 590 Medicare patients who saw Dr. Brill in 2024. The largest group is 65 to 74, with 282 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brill's median patient age at 70, with 52% women.

In 2024, Dr. Brill wrote 205 Medicare Part D claims for 58 patients. 60% of them were for generic drugs. CMS names the drug for 183 of them, across 6 drugs with 11 or more claims each, at $6,978 in total drug cost. In 2023, CMS named 36 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Brill for performance year 2024, reported as part of a group. Dr. Brill accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Brill, published from 2019 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Fluorescein Angiography, Uveitis and Visual Acuity. Dr. Brill has published most often in Am J Ophthalmol Case Rep. Dr. Brill's most frequent co-authors are Lucia Sobrin, MD, MPH, Taylor Fields, MD and Desiree C. Albert, MD.

CMS Open Payments shows 99 general payments to Dr. Brill from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $1,251.